Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [14862]

Spouses’ mood may impact the well-being of cancer survivors

Spouses’ mood may impact the well-being of cancer survivors

ASCO 2015: MEDI4736 tremelimumab combo shows activity in NSCLC

ASCO 2015: MEDI4736 tremelimumab combo shows activity in NSCLC

ASCO 2015: Phase III study finds initial nivolumab-based treatment halts melanoma progression

ASCO 2015: Phase III study finds initial nivolumab-based treatment halts melanoma progression

ASCO 2015: Preventive neck lymph node surgery improves early oral cancer survival

ASCO 2015: Preventive neck lymph node surgery improves early oral cancer survival

ASCO 2015: First effective adjuvant chemotherapy for high-risk, localised prostate cancer

ASCO 2015: First effective adjuvant chemotherapy for high-risk, localised prostate cancer

ASCO 2015: Extensive lymph node surgery may not be necessary for some patients with melanoma

ASCO 2015: Extensive lymph node surgery may not be necessary for some patients with melanoma

ASCO 2015: First-in-class targeted drug daratumumab shows promise in heavily treatment-resistant multiple myeloma

ASCO 2015: First-in-class targeted drug daratumumab shows promise in heavily treatment-resistant multiple myeloma

ASCO 2015: Anastrazole offers higher breast cancer-free survival rates than tamoxifen following DCIS

ASCO 2015: Anastrazole offers higher breast cancer-free survival rates than tamoxifen following DCIS

ASCO 2015: Novel targeted drug palbociclib slows progression of hormone receptor-positive breast cancer

ASCO 2015: Novel targeted drug palbociclib slows progression of hormone receptor-positive breast cancer

ASCO 2015: Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma

ASCO 2015: Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma

More from ecancer